Matt Scranton

Matt Scranton is currently employed as a Real-World Evidence Research Analyst at TriNetX since June 2024. Prior experience includes roles at Lyndra Therapeutics from August 2020 to August 2024, where Matt served as a Clinical Research Consultant, Clinical Scientist, and Senior Clinical Trial Administrator. Previously, Matt worked as a Clinical Research Coordinator at Dana-Farber Cancer Institute in the Center for Immuno-Oncology from July 2018 to August 2020. Matt's background also includes military service in the US Navy as a Fleet Marine Force Corpsman from 2013 to 2020, supporting the 1st Battalion, 25th Reserve Marine Regiment. In addition, Matt gained experience as a Public Health Intern at Harvard T.H. Chan School of Public Health in 2016. Educational qualifications include a Master of Science in Epidemiology from the University of Massachusetts Amherst and a Bachelor of Science in Biology from UMass Boston.